Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.39 |
| ▸ | WDR5 | P61964 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8075590 | 0.80 | GPR84 (0.49) | TAAR1GPR84MAPTALDH1A1CYP2A6 | |
| SCHEMBL21214530 | 0.80 | GPR84 (0.49) | TAAR1GPR84MAPTALDH1A1CYP2A6 | |
| SCHEMBL14234929 | 0.78 | TAAR1 (0.44) | TAAR1GPR84MAPTALDH1A1CYP2A6 | |
| SCHEMBL83697 | 0.77 | TAAR1 (0.40) | TAAR1GPR84MAPTALDH1A1HSD17B10 | |
| SCHEMBL10035139 | 0.76 | CYP19A1 (0.55) | TAAR1GPR84MAPTALDH1A1CYP2A6 | |
| SCHEMBL80771 | 0.76 | TAAR1 (0.39) | TAAR1GPR84MAPTALDH1A1KDM4E | |
| SCHEMBL17722902 | 0.75 | TAAR1 (0.42) | TAAR1GPR84MAPTALDH1A1CYP2A6 | |
| SCHEMBL83992 | 0.73 | GPR84 (0.46) | TAAR1GPR84MAPTALDH1A1CYP2A6 | |
| SCHEMBL21214529 | 0.73 | CYP2A6 (0.42) | TAAR1GPR84MAPTALDH1A1CYP2A6 | |
| SCHEMBL23436413 | 0.72 | CYP19A1 (0.48) | TAAR1GPR84MAPTALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9057018-B2 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and polymer thereof | JNC CORPORATION (JP) | 2015-06-16 | — | — | US | disclosed |
| US-9057018-B2 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and polymer thereof | JNC CORPORATION (JP) | 2015-06-16 | — | — | US | disclosed |
| US-8455061-B2 | Optically active compound having polymerizable group and its polymer | JNC CORPORATION (JP) | 2013-06-04 | — | — | US | disclosed |
| US-8455061-B2 | Optically active compound having polymerizable group and its polymer | JNC CORPORATION (JP) | 2013-06-04 | — | — | US | disclosed |
| US-8425988-B2 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition and anisotropic polymer | JNC CORPORATION (JP) | 2013-04-23 | — | — | US | disclosed |
| US-8425988-B2 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition and anisotropic polymer | JNC CORPORATION (JP) | 2013-04-23 | — | — | US | disclosed |
| US-8404316-B2 | Polymerizable liquid crystal compound and its polymer | JNC CORPORATION (JP) | 2013-03-26 | — | — | US | disclosed |
| US-8366962-B2 | Polymerizable liquid crystal compounds having oxiranyl group, polymerizable liquid crystal compositions and polymers | JNC CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8366962-B2 | Polymerizable liquid crystal compounds having oxiranyl group, polymerizable liquid crystal compositions and polymers | JNC CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8354147-B2 | Polymerizable liquid crystal compound, composition and polymer | JNC CORPORATION (JP) | 2013-01-15 | — | — | US | disclosed |
| US-20100304148-A1 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and polymer thereof | CHISSO CORPORATION | 2010-12-02 | — | — | US | disclosed |
| US-20100304148-A1 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and polymer thereof | CHISSO CORPORATION | 2010-12-02 | — | — | US | disclosed |
| US-20100297367-A1 | OPTICALLY ANISOTROPIC SUBSTANCE | CHISSO CORPORATION (JP) | 2010-11-25 | — | — | US | disclosed |
| EP-1658350-B1 | COMPOUNDS FOR USE IN LIQUID CRYSTAL MEDIA | MERCK PATENT GMBH (DE) | 2010-01-20 | — | — | EP | disclosed |
| EP-1658351-B1 | MESOGENIC COMPOUNDS, MEDIUM FOR ELECTRO-OPTICAL DISPLAYS AND ELECTRO-OPTICAL DISPLAY | MERCK PATENT GMBH (DE) | 2009-10-28 | — | — | EP | disclosed |
| US-7531106-B2 | Mesogenic compounds, medium for electro-optical displays and electro-optical display | MERCK PATENT GMBH (DE) | 2009-05-12 | — | — | US | disclosed |
| US-7531106-B2 | Mesogenic compounds, medium for electro-optical displays and electro-optical display | MERCK PATENT GMBH (DE) | 2009-05-12 | — | — | US | disclosed |
| US-7440160-B2 | Electro-optical light modulating element, electro-optical display and modulating medium | MERCK PATENT GMBH (DE) | 2008-10-21 | — | — | US | disclosed |
| US-7440160-B2 | Electro-optical light modulating element, electro-optical display and modulating medium | MERCK PATENT GMBH (DE) | 2008-10-21 | — | — | US | disclosed |
| EP-1561150-B1 | ELECTROOPTICAL LIGHT MODULATING ELEMENT, ELECTROOPTICAL DISPLAY AND MODULATING MEDIUM | MERCK PATENT GMBH (DE) | 2007-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100304148-A1 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and polymer thereof | SSB, CNKSR1, RCC1 | TAAR1 1093/4885GPR84 3008/4885MAPT 620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.